Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 4 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20122
20131
20151
20161
20171
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LMC Diabetes & Endocrinology Ltd.2
CHU de Quebec-Universite Laval1
Institut de Recherches Cliniques de Montreal1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Novo Nordisk A/S1
Ottawa Hospital Research Institute1
Sanofi1
Smith & Nephew, Inc.1
University Health Network, Toronto1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 112
Diabetes Mellitus7
Diabetes Mellitus, Type 22
Insulin Resistance2
Cardiovascular Diseases1
Diabetes Complications1
Diabetic Foot1
Diabetic Nephropathies1
Hyperglycemia1
Hypertension1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.